Skip to main content

US plans stem cell bank

But researchers and advocates call plan 'too little, too late'

Written byAnne Harding
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

A National Institutes of Health (NIH) plan announced last week (July 14) to grow and distribute Bush administration–approved stem cell lines remains in the very early stages, and researchers and advocates call the proposal a political move that will do nothing to get stem cell therapies to the clinic.

No site for the proposed stem cell bank has been chosen, no steering committee has been named, and while a small amount of funds has been set aside for planning for the remainder of this fiscal year, spending for fiscal year 2005 has not been determined, an NIH spokesperson told The Scientist. "It might involve some construction and will certainly involve negotiation with the holders of the stem cells," the spokesperson said.

The Department of Health and Human Services (DHHS) described the stem cell bank plans in two sentences in a three-page fact sheet on embryonic stem cells published July 14. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo